NO20065735L - Farmasoytiske sammensetninger omfattende ZD6474 - Google Patents

Farmasoytiske sammensetninger omfattende ZD6474

Info

Publication number
NO20065735L
NO20065735L NO20065735A NO20065735A NO20065735L NO 20065735 L NO20065735 L NO 20065735L NO 20065735 A NO20065735 A NO 20065735A NO 20065735 A NO20065735 A NO 20065735A NO 20065735 L NO20065735 L NO 20065735L
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
diluent
tough
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
NO20065735A
Other languages
English (en)
Other versions
NO338324B1 (no
Inventor
Paul William Stott
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20065735L publication Critical patent/NO20065735L/no
Publication of NO338324B1 publication Critical patent/NO338324B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Farmasøytisk preparat omfattende ZD6474, eller et farmasøytisk akseptabelt salt derav, et sprøtt fortynningsmiddel og et andre fortynningsmiddel som er praktisk talt uoppløselig og har seige kompresjonsegenskaper.
NO20065735A 2004-05-21 2006-12-12 Farmasøytiske sammensetninger omfattende ZD6474 NO338324B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0411378.3A GB0411378D0 (en) 2004-05-21 2004-05-21 Pharmaceutical compositions
PCT/GB2005/001931 WO2005112934A1 (en) 2004-05-21 2005-05-18 Pharmaceutical compositions comprising zd6474

Publications (2)

Publication Number Publication Date
NO20065735L true NO20065735L (no) 2006-12-19
NO338324B1 NO338324B1 (no) 2016-08-08

Family

ID=32607743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065735A NO338324B1 (no) 2004-05-21 2006-12-12 Farmasøytiske sammensetninger omfattende ZD6474

Country Status (33)

Country Link
US (1) US8067427B2 (no)
EP (1) EP1753431B1 (no)
JP (1) JP4740947B2 (no)
KR (1) KR101192935B1 (no)
CN (1) CN101031303B (no)
AR (2) AR049059A1 (no)
AT (1) ATE439841T1 (no)
AU (1) AU2005244650B2 (no)
BR (1) BRPI0511253B8 (no)
CA (1) CA2565513C (no)
CY (1) CY1109500T1 (no)
DE (1) DE602005016105D1 (no)
DK (1) DK1753431T3 (no)
ES (1) ES2330025T3 (no)
GB (1) GB0411378D0 (no)
HR (1) HRP20090547T1 (no)
IL (1) IL178928A (no)
ME (2) ME01505B (no)
MX (1) MXPA06013501A (no)
MY (1) MY138868A (no)
NO (1) NO338324B1 (no)
NZ (1) NZ550931A (no)
PL (1) PL1753431T3 (no)
PT (1) PT1753431E (no)
RS (1) RS51112B (no)
RU (1) RU2383343C2 (no)
SA (1) SA05260133B1 (no)
SI (1) SI1753431T1 (no)
TW (1) TWI355269B (no)
UA (1) UA81732C2 (no)
UY (1) UY28901A1 (no)
WO (1) WO2005112934A1 (no)
ZA (1) ZA200609110B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278511B1 (es) * 2005-07-28 2008-06-16 Laboratorios Almirall S.A. Comprimidos con perfil de disolucion mejorado.
ES2813877T3 (es) 2013-08-28 2021-03-25 Crown Bioscience Inc Taicang Distintivos de expresión génica predictivos de la respuesta de un sujeto a un inhibidor multicinasa y métodos de uso de los mismos
WO2025256594A1 (en) * 2024-06-12 2025-12-18 Centre for Eye and Vision Research Limited Methods and compositions for treating refractive errors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718972D0 (en) * 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
KR100881105B1 (ko) * 1999-11-05 2009-02-02 아스트라제네카 아베 Ｖｅｇｆ 억제제로서의 퀴나졸린 유도체
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
KR100419555B1 (ko) * 2000-05-29 2004-02-19 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
GB0126879D0 (en) * 2001-11-08 2002-01-02 Astrazeneca Ab Combination therapy
JP4542783B2 (ja) * 2002-03-05 2010-09-15 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有複素環化合物及び血管新生抑制剤とを組み合わせてなる抗腫瘍剤

Also Published As

Publication number Publication date
TW200612953A (en) 2006-05-01
CA2565513A1 (en) 2005-12-01
US8067427B2 (en) 2011-11-29
US20070244323A1 (en) 2007-10-18
CN101031303B (zh) 2011-08-31
BRPI0511253A (pt) 2007-11-27
HK1099220A1 (en) 2007-08-10
DK1753431T3 (da) 2009-11-16
BRPI0511253B1 (pt) 2020-03-31
KR20070034499A (ko) 2007-03-28
AR049059A1 (es) 2006-06-21
PT1753431E (pt) 2009-10-14
RU2006145357A (ru) 2008-06-27
NZ550931A (en) 2009-05-31
SI1753431T1 (sl) 2009-12-31
EP1753431A1 (en) 2007-02-21
TWI355269B (en) 2012-01-01
AU2005244650A1 (en) 2005-12-01
MY138868A (en) 2009-08-28
CY1109500T1 (el) 2014-08-13
BRPI0511253B8 (pt) 2021-05-25
AU2005244650B2 (en) 2008-04-10
RU2383343C2 (ru) 2010-03-10
JP4740947B2 (ja) 2011-08-03
KR101192935B1 (ko) 2012-10-18
ME02778B (me) 2010-10-31
PL1753431T3 (pl) 2009-12-31
GB0411378D0 (en) 2004-06-23
ME01505B (me) 2014-04-20
WO2005112934A1 (en) 2005-12-01
HRP20090547T1 (hr) 2009-11-30
UA81732C2 (ru) 2008-01-25
JP2007538060A (ja) 2007-12-27
EP1753431B1 (en) 2009-08-19
NO338324B1 (no) 2016-08-08
CA2565513C (en) 2010-10-19
ATE439841T1 (de) 2009-09-15
MXPA06013501A (es) 2007-06-12
ZA200609110B (en) 2008-06-25
ES2330025T3 (es) 2009-12-03
UY28901A1 (es) 2005-12-30
RS51112B (sr) 2010-10-31
IL178928A0 (en) 2007-03-08
IL178928A (en) 2012-04-30
SA05260133B1 (ar) 2008-12-23
AR110045A2 (es) 2019-02-20
CN101031303A (zh) 2007-09-05
DE602005016105D1 (de) 2009-10-01

Similar Documents

Publication Publication Date Title
NO20082793L (no) Nye tiofenderivater
SA521422143B1 (ar) 15-pgdh مثبط
NO20092611L (no) Krystallinsk faststoff Rasagilin base
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
NO20076288L (no) Farmasoytiske sammensetninger innbefattende imatinib og et frigivningssinkende middel
WO2006020994A3 (en) Compositions and methods using hyaluronic acid and hyluronidase inhibitors
DK1797281T3 (da) Fremgangsmåde til at estimere et bruds geometri, såvel som sammensætninger og artikler anvendt dertil
WO2007078726A3 (en) Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
NO20092609L (no) Tannate salt of rasagiline
WO2005117870A3 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
EA200700566A1 (ru) Фармацевтические композиции, включающие леветирацетам, и способы их получения
NO20075920L (no) Assosiasjon mellom ferroquin og et artemisininderivat for behandling av malaria
NO20083462L (no) Nye tiofenderivater som S1P1/EDG1-reseptoragonister
CY1115381T1 (el) Διενυδρη υδροχλωρικη ναλμεφαινη
NO20083836L (no) N-hydroksyakrylamidforbindelser
EA200801619A1 (ru) Способ улучшения фармакокинетики ингибиторов интегразы вич (варианты), набор и фармацевтическая композиция (варианты)
WO2009032843A3 (en) Deuterated ethambutols and their use
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
EA201071024A1 (ru) Смесь для получения быстро разрушающихся таблеток
NO20065735L (no) Farmasoytiske sammensetninger omfattende ZD6474
WO2007106494A3 (en) Methods and compositions for treatment of diastolic heart failure
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GENZYME CORPORATION, US

MM1K Lapsed by not paying the annual fees